格拉尼尔格拉尼尔二酸盐合成酶缺乏会损害急性肺损伤的效细胞化和解决
Jiajia Jin1,2, Lihong Ma1,3, Lulu Li2
1Department of Respiratory and Critical Care Medicine, Jinling Hospital, Nanjing Medical University, #305, East Zhongshan Road, Nanjing, 210002, China.
Respiratory research
|May 16, 2025
概括
格拉尼尔格拉尼尔二酸合成酶 (GGPPS) 对于清除急性呼吸困扰综合征 (ARDS) 中的死细胞至关重要. 增强GGPPS功能可能会改善肺损伤的解决方案,并提供新的ARDS疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
背景情况:
- 急性呼吸窘迫综合征 (ARDS) 是一种具有高死亡率的严重疾病.
- 巨细胞损害的细胞 (细胞的清除) 会加剧ARDS炎症.
- 在ARDS中调节细胞的机制尚未完全理解.
研究的目的:
- 在肺损伤恢复过程中,研究基拉尼尔基拉尼尔二酸盐合成酶 (GGPPS) 在细胞分裂中的作用.
- 阐明GGPPS在ARDS中影响巨细胞功能的分子机制.
- 评估GGPPS作为ARDS的潜在治疗点.
主要方法:
- 在急性肺损伤 (ALI) 期间对肺巨细胞和单细胞GGPPS表达的分析.
- 使用骨髓细胞特异性GGPPS淘汰赛 (CKO) 小鼠来评估肺炎和血细胞分裂.
- 研究了GGPPS缺乏对AXL信号和巨细胞行为 in vitro和 in vivo的影响.
- 给CKO小鼠注射格拉尼尔格拉尼奥尔 (GGOH),以评估治疗潜力.
主要成果:
- 在ALI进展和解决过程中,GGPPS表达力学变化.
- GGPPS CKO小鼠表现出长时间的炎症,亡性中性粒细胞的增加和巨细胞招募的改变.
- 通过破坏AXL信号传递,GGPPS缺乏症对被招募和居住的巨细胞中受影响.
- 在GGPPS CKO小鼠中,GGOH治疗挽救了肺损伤的消失,并恢复了血细胞分裂.
结论:
- 在肺损伤解决过程中,GGPPS是被招募的巨细胞中效细胞的关键调节者.
- 通过AXL信号传递,GGPPS调节了细胞形成.
- 针对GGPPS提供了一个有希望的治疗策略,可以加速ARDS恢复.
相关概念视频
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Acute Respiratory Failure-II
157
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
157
Acute Respiratory Failure-I
157
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
157
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
IP3/DAG Signaling Pathway
11.7K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


